PMON60 Growth Hormone (GH) Replacement Therapy (GHRT) in Patients with Adult GH Deficiency (AGHD) Aged ≥60 Years: Data from NordiNet® IOS and the ANSWER Program

There are limited data on the effectiveness and safety of GHRT in older patients with AGHD. We compared real-world GHRT outcomes in older (aged ≥60 years) versus middle-aged (35–<60 years) adults. NordiNet® IOS (NCT00960128) and ANSWER (NCT01009905) were non-interventional studies investigating l...

Descripción completa

Detalles Bibliográficos
Autores principales: Biller, Beverly, Gordon, Murray, Höybye, Charlotte, Olsen, Anne, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625479/
http://dx.doi.org/10.1210/jendso/bvac150.1159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625479/
http://dx.doi.org/10.1210/jendso/bvac150.1159

Ejemplares similares